Budget Impact Analysis of Stepping Down Patients from Long-Term Inappropriate Proton Pump Inhibitor Use to Episodic Alginate Treatment: NHS England Perspective
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | Reckitt Benckiser |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
par: Yi‐Fan Chien, et autres
Publié: (2025)
par: Yi‐Fan Chien, et autres
Publié: (2025)
Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors
par: Maxwell Rossip, et autres
Publié: (2025)
par: Maxwell Rossip, et autres
Publié: (2025)
Proton Pump Inhibitor Use and Its Association With Asthma: A Systematic Review and Meta‐Analysis
par: Ganesh Bushi, et autres
Publié: (2025)
par: Ganesh Bushi, et autres
Publié: (2025)
Proton Pump Inhibitor Use and Incident Cardiovascular Disease in Older Postmenopausal Women
par: Ahmed I. Soliman, et autres
Publié: (2024)
par: Ahmed I. Soliman, et autres
Publié: (2024)
Use of Proton Pump Inhibitors Among Patients With Alcohol‐Related Cirrhosis—A Danish Nationwide Cohort Study
par: Marine Sølling Ramsing, et autres
Publié: (2025)
par: Marine Sølling Ramsing, et autres
Publié: (2025)
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis
par: Giulia Bandini, et autres
Publié: (2024)
par: Giulia Bandini, et autres
Publié: (2024)
Proton Pump Inhibitors and Alcohol‐Related Cirrhosis
par: Shih‐Wei Lai
Publié: (2025)
par: Shih‐Wei Lai
Publié: (2025)
Proton Pump Inhibitors and Quality of Life in Patients with Globus Pharyngeus: An Observational Study
par: Valeria Arango-García
Publié: (2025)
par: Valeria Arango-García
Publié: (2025)
The Cost of Adrenal Insufficiency in England—Analysis of NHS HES Data
par: Robert D. Murray, et autres
Publié: (2025)
par: Robert D. Murray, et autres
Publié: (2025)
Proton Pump Inhibitor Use Exceeding the U.S. Food and Drug Administration Approved Treatment Duration for Patients With Peptic Ulcer Disease: A Retrospective Cohort Study
par: Jordan A. Villars, et autres
Publié: (2025)
par: Jordan A. Villars, et autres
Publié: (2025)
Response to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia
par: Andrea Estefanía Rodríguez López, et autres
Publié: (2025)
par: Andrea Estefanía Rodríguez López, et autres
Publié: (2025)
Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors
par: Philip Kitchen, et autres
Publié: (2026)
par: Philip Kitchen, et autres
Publié: (2026)
Response: Proton Pump Inhibitors and Alcohol‐Related Cirrhosis
par: Marine Sølling Ramsing, et autres
Publié: (2025)
par: Marine Sølling Ramsing, et autres
Publié: (2025)
Proton Pump Inhibitors: Are we prescribing them right?
par: Eduardo Esteban-Zubero
Publié: (2021)
par: Eduardo Esteban-Zubero
Publié: (2021)
Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study
par: Nicolas Cortes‐Mejia, et autres
Publié: (2026)
par: Nicolas Cortes‐Mejia, et autres
Publié: (2026)
Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
par: Kee Huat Chuah, et autres
Publié: (2024)
par: Kee Huat Chuah, et autres
Publié: (2024)
The Use of Proton Pump Inhibitors Among Adults in Norway—A Nationwide Drug Utilization Study
par: Reidar Fossmark, et autres
Publié: (2025)
par: Reidar Fossmark, et autres
Publié: (2025)
Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents
par: Hiroyuki Shibata, et autres
Publié: (2025)
par: Hiroyuki Shibata, et autres
Publié: (2025)
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
par: Shoko Miyahara, et autres
Publié: (2025)
par: Shoko Miyahara, et autres
Publié: (2025)
Alarming Trends in Proton Pump Inhibitor (PPI) Misuse in Bangladesh
par: Md Nasir Ahmed, et autres
Publié: (2025)
par: Md Nasir Ahmed, et autres
Publié: (2025)
Effect of Butyrate‐Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab
par: Kazuhiro Nouso, et autres
Publié: (2026)
par: Kazuhiro Nouso, et autres
Publié: (2026)
Assessing Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Incidence of Major Adverse Cardiovascular Events: A Retrospective Cohort Study
par: Aljoharah M. Algabbani, et autres
Publié: (2025)
par: Aljoharah M. Algabbani, et autres
Publié: (2025)
Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study
par: Deepika Dinesh, et autres
Publié: (2025)
par: Deepika Dinesh, et autres
Publié: (2025)
Chronic Use of Proton Pump Inhibitors Is Associated With Reduced 30‐Day Mortality From Acute Pancreatitis
par: Maya Fischman, et autres
Publié: (2025)
par: Maya Fischman, et autres
Publié: (2025)
The role of NHS Resolution in the maternity safety landscape in England
par: Alison Wonnacott, et autres
Publié: (2025)
par: Alison Wonnacott, et autres
Publié: (2025)
Proton‐Pump Inhibitor Use and Gastrointestinal Disease Risk: A Mendelian Randomization Study of Omics and Pharmacological Pathways
par: Weixiong Zhu, et autres
Publié: (2025)
par: Weixiong Zhu, et autres
Publié: (2025)
Editorial: Proton Pump Inhibitors and the Changing Face of Spontaneous Bacterial Peritonitis
par: S. Quickert, et autres
Publié: (2026)
par: S. Quickert, et autres
Publié: (2026)
Prophylactic Proton Pump Inhibitors in Critically Ill Patients Undergoing Invasive Ventilation: A Systematic Review and Meta‐Analysis of Randomized Trials
par: Jinlu Hu, et autres
Publié: (2026)
par: Jinlu Hu, et autres
Publié: (2026)
Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators
par: Marthe J. Huntelaar, et autres
Publié: (2025)
par: Marthe J. Huntelaar, et autres
Publié: (2025)
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply
par: Kee Huat Chuah, et autres
Publié: (2025)
par: Kee Huat Chuah, et autres
Publié: (2025)
Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
par: Majid Khalilizad, et autres
Publié: (2025)
par: Majid Khalilizad, et autres
Publié: (2025)
Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis
par: Magnus A. B. Axelsson, et autres
Publié: (2025)
par: Magnus A. B. Axelsson, et autres
Publié: (2025)
Clinical Profiles and Proton Pump Inhibitor Discontinuation Outcomes in Laryngopharyngeal Reflux Disease
par: Lea Geoffroy, et autres
Publié: (2025)
par: Lea Geoffroy, et autres
Publié: (2025)
Growth Inhibitors for Suppressing Inappropriate Image Concepts in Diffusion Models
par: Chen, Die, et autres
Publié: (2024)
par: Chen, Die, et autres
Publié: (2024)
Treatment With Phosphodiesterase 5 Inhibitors and Long‐Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization
par: Sumon Roy, et autres
Publié: (2025)
par: Sumon Roy, et autres
Publié: (2025)
NHS England commissioning framework for children and young people with cerebral palsy
par: Charlie Fairhurst
Publié: (2025)
par: Charlie Fairhurst
Publié: (2025)
Dynamic Relevance Between Reflux Events and Esophageal Motility in Patients With Proton Pump Inhibitor‐Refractory Gastroesophageal Reflux Disease
par: Si Hui Lin, et autres
Publié: (2025)
par: Si Hui Lin, et autres
Publié: (2025)
Effect of Acupuncture on Pneumonia Risk in Stroke Patients using Proton Pump Inhibitors: A Retrospective Case‐Control Study
par: Shaokang Wang, et autres
Publié: (2025)
par: Shaokang Wang, et autres
Publié: (2025)
Response to Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
par: Keisuke Mine, et autres
Publié: (2025)
par: Keisuke Mine, et autres
Publié: (2025)
Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study
par: Ahmed I. Soliman, et autres
Publié: (2025)
par: Ahmed I. Soliman, et autres
Publié: (2025)
Documents similaires
-
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
par: Yi‐Fan Chien, et autres
Publié: (2025) -
Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors
par: Maxwell Rossip, et autres
Publié: (2025) -
Proton Pump Inhibitor Use and Its Association With Asthma: A Systematic Review and Meta‐Analysis
par: Ganesh Bushi, et autres
Publié: (2025) -
Proton Pump Inhibitor Use and Incident Cardiovascular Disease in Older Postmenopausal Women
par: Ahmed I. Soliman, et autres
Publié: (2024) -
Use of Proton Pump Inhibitors Among Patients With Alcohol‐Related Cirrhosis—A Danish Nationwide Cohort Study
par: Marine Sølling Ramsing, et autres
Publié: (2025)